Impact Corelab to Move to New Corporate Headquarters in Sacramento
Impact Corelab, Inc. (ICI) announced the completion of work on its new corporate headquarters suite in Sacramento. In March, the company plans to move staff and operations into the facility, which adjoins the offices of Radiological Associates of Sacramento (RAS), whose radiologists provide specialized medical resources and support for customers of ICI’s imaging corelab services. The move is expected to enable a high degree of strategic collaboration between the two firms.
Located at 1500 Expo Parkway in Sacramento, the newly built office suite will allow ICI to concentrate its core activities in one location, including executive leadership, imaging operations, radiology read workstations, business development, data hosting/management, customer support and project management.
“We are pleased with the completion of our new headquarters space,” said Dr. Benjamin Franc M.D., M.S., acting CEO and Chairman of the Board. “This is an opportunity for us to consolidate the key corporate functions that will help fuel future growth as well as providing us with the proximity we wanted to enable close collaboration with our radiological affiliate, RAS, to serve the needs of ICI’s growing customer base.”
RAS’ team of 1,000 radiology professionals includes doctors, radiology specialists, and project managers to help support customers of ICI, which combines cloud-based data on demand technology with radiological services to deliver transparency, reliability, and query reduction for sponsors and CROs in image-based trials.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
